CCM
PAHC icon

Chilton Capital Management’s Phibro Animal Health PAHC Stock Holding History

Chilton Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30
Closed -$1.12K – 719
2025
Q4 		$1.12K Buy
+30
New +$1.22K ﹤0.01% 580

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Chilton Capital Management's PAHC Position: Q1 2026 in Review

Chilton Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 30 shares — an estimated $1.12K sold.

Chilton Capital Management first reported a position in PAHC in Q4 2025 and held it in 1 quarter. The position peaked at $1.12K in Q4 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Chilton Capital Management reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Chilton Capital Management sold 30 Phibro Animal Health shares in Q1 2026, an estimated $1.12K.
  • Chilton Capital Management first reported a position in Phibro Animal Health in Q4 2025 and held it in 1 quarter.
  • Chilton Capital Management's Phibro Animal Health position peaked at $1.12K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.